PSYC is our new TINY float trade idea

Published: Tue, 07/28/20

Subscribers,

Our last trade idea delivered major upside for us, but we think today's pick could be much better.

Get Global Trac Solutions, Inc (PSYC) on your screen immediately.

PSYC has a market cap of just $1.6m and an even smaller float. And best of all, is priced at just over $0.01. This means every trader should have PSYC on their radar.

The chart is super hot too. As you can see below there is major multi month support at $0.01, just below where PSYC sits now.

You can also see the potential for upside with PSYC making some epic moves higher in the past few months.

Back in April it ran from $0.01 to $0.05 in just a few days - that's an incredible 400% gain!!

And then in June, it ran from $0.02 to around $0.047 for close to a 135% gain!!

Now with PSYC consolidating at just above long term support, we think there could be another explosive upside move on the cards.

Breaking News...

The Exponential Growth of PSYC's Website Users Leads to Record Setting Day for www.psychedelicspotlight.com

LAS VEGAS, July 27, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that daily website traffic analytics observed in recent weeks associated with the Company’s Psychedelic Spotlight website (www.psychedelicspotlight.com) has demonstrated a steady increase in daily visitors which is highlighted by over 4,000 visitors to the site on the 15^th of July alone, a new daily record for the website.

The Company contends that a contributing factor to the significant surge in visitors to the website on July 15^th was due in large part to the release of the 2^nd edition of their Microdose Monthly newsletter to its growing base of subscribers on that day, in addition to the recent launch of its social media platforms, as well as other related networking efforts it is beginning to leverage as a means of increasing its presence within the burgeoning medicinal psychedelic space.

Said Global Trac Solutions, Inc. CEO, David Flores: “It is extremely encouraging to see some of the awareness-driven initiatives we have deployed in recent weeks begin to demonstrate their value through positive data and analytics. As you know, developing a recognized brand and identity for ourselves within the emerging medicinal psychedelic space is a very critical part of placing us on a reasonable path to tapping into a variety of different revenue streams as we forward with our expansion. By driving more traffic to our Psychedelic Spotlight website and increasing subscribership to our Microdose Monthly newsletter, I believe we are in the process of positioning ourselves quite effectively to begin creating revenue opportunities through things like online display advertising in addition to being in a more prominent position to explore potential partnership opportunities within this dynamic space.”

The Company intends to continue the growth of each of its platforms by remaining committed to efforts involved in connecting with some of the most recognized leaders and prominent advocates within the rapidly expanding medicinal psychedelic industry.

Read in full at https://finance.yahoo.com/news/exponential-growth-psycs-website-users-123000028.html

About PSYC...

Global Trac Solutions (PSYC) is a diversified holding company dedicated to identifying new and emerging industries. By utilizing our years of business development expertise our diverse team of innovators continuously leverages our experience to effectively execute go-to-market strategies in order to position ourselves for rapid growth through the creation of an evolving business foundation to enhance profitability potential.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

To learn more, visit https://www.globaltracsolutions.com/

PSYC Interviews Chief Architects and Petitioners of Oregon’s Psilocybin Therapy Initiative

LAS VEGAS, July 21, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce the release of a special edition of its Microdose Monthly newsletter featuring an exclusive interview conducted by PSYC CEO, David Flores, and long-time psilocybin therapy advocates and Chief Petitioners of Initiative Petition 34 (“IP 34”) in the state of Oregon, Tom and Sheri Eckert.

Distributed this morning to Microdose Monthly subscribers, and now live on the Psychedelic Spotlight website under Spotlight Originals, the interview highlights the recent accomplishment of the IP 34 campaign team, guided, and led by chief architects, Tom and Sheri Eckert, in helping to secure the nearly 165,000 signatures required to place the initiative on the ballot in Oregon this November and providing Oregonians with the opportunity to potentially green light a state licensed and regulated psilocybin therapy program within the state.

According to data provided by Mental Health America , Oregon is currently ranked as one of the worst/bottom states in the U.S. in terms of its prevalence of mental health illnesses and disorders amongst its residents in addition to significantly lower rates of access to care when compared to other states. Such conditions, compounded by the recent COVID-19 pandemic, have created a significant mental health epidemic within the state and particularly for those struggling with a variety of illnesses and disorders such as depression, anxiety, and addiction. Based on encouraging data from research and studies performed by leading medical research institutions such as Johns Hopkins, UCLA, and NYU, Psilocybin therapy through IP 34 aims to provide Oregonians with a much needed alternative to conventional, and mostly pharma-based drugs, whereby placing more emphasis on treatment over management.

“I would first like to extend my sincerest gratitude and congratulations to Tom and Sheri Eckert for their tireless efforts, leadership, and dedication that have contributed to IP 34 earning a very important spot on the November ballot in Oregon,” said Global Trac Solutions, Inc. CEO, David Flores. “This represents a potentially exciting and critical step forward for the thousands of Oregonians struggling everyday with a variety of debilitating mental health illnesses and disorders in terms of laying the groundwork for expanded treatment options highlighted by a licensed and regulated psilocybin therapy program. In my opinion, this also represents an especially significant step forward for the psychedelic reform movement and industry as a whole and demonstrates the tangible momentum it is continuing to gain. And as this momentum continues to pick up traction, I look forward to maximizing the use of our Psychedelic Spotlight (www.psychedelicspotlight.com)and Microdose Monthly platforms to showcase many other leaders within this space who are contributing to its growth and emergence as a legitimate and full-fledged industry.”

PSYC encourages those interested in learning more about IP 34, or contributing to the initiative, to visit the campaigns primary website at: https://yesonip34.org/

Read in full at https://finance.yahoo.com/news/psyc-interviews-chief-architects-petitioners-123010241.html

PSYC Expands its Reach with the Launch of Social Media Platforms

PSYC Offers Fresh Look at Emerging Psilocybin Community with July Newsletter

PSYC To Expand Industry Outreach Efforts With Launch of Social Media Platforms

So, PSYC is set up perfectly for a potentially major move higher.

With a tiny market cap and float, big recent news catalysts and a hot chart, we think PSYC will be on every trader and investors screen.

Don't miss out, make sure you join them.

All the best.

SmallCapMomo.com

picks@smallcapmomo.com

--------------------------------------------------------------------------------------------------------

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.

Disclaimer
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. For full disclaimer click here. SmallCapMomo.com is the property of Alpha Stock Media. SmallCapMomo.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. The disclaimer is to be read and fully understood before using our site, or joining our email list. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SmallCapMomo.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. SmallCapMomo.com does not offer such advice or analysis, and SmallCapMomo.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, SmallCapMomo.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SmallCapMomo.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents have not completed any due diligence or research on the companies advertised herein and disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SmallCapMomo.com is not responsible for any claims made by the companies advertised herein. SmallCapMomo.com may receive compensation and they, its employees and/or affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in SmallCapMomo.com statements and opinions and such statements and opinions cannot be considered independent. SmallCapMomo.com reserves the right to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, SmallCapMomo.com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. SmallCapMomo.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to close positions they have entered into at any given time including before or after the release of the companies profile. Alpha Stock Media has been compensated one thousand five hundred dollars via electronic transfer from a non-affiliated third party for the profile of PSYC. SmallCapMomo.com does not accept compensation in restricted or free-trading shares for its marketing services of the company being profiled. However the third party that has compensated SmallCapMomo.com may hold free-trading shares of the company being profiled and could very well be selling shares of the company’s stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If SmallCapMomo.com ever does accept compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the position of those free trading shares received as compensation for our services at the time our promotional material is released to the public, as well as information on our intention to sell these shares during the promotional period or thereafter.